Apellis Pharmaceuticals, Inc.
APLSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Apellis Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Apellis Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wheeler Craig A | Director | 0 | May 14, 2026 | 2 |
| Dolsten Mikael | Director | 0 | May 14, 2026 | 2 |
| Machiels Alec | Director | 0 | May 14, 2026 | 2 |
| Chan Gerald | Director | 0 | May 14, 2026 | 2 |
| Watson David O. | General Counsel | 0 | May 14, 2026 | 9 |
| Deschatelets Pascal | Chief Scientific Officer | 0 | May 14, 2026 | 5 |
| Francois Cedric | Chief Executive Officer | 0 | May 14, 2026 | 7 |
| Sullivan Timothy Eugene | Chief Financial Officer | 0 | May 14, 2026 | 7 |
| O'Brien Stephanie Monaghan | Director | 0 | May 14, 2026 | 3 |
| Dunlop A. Sinclair | Director | 0 | May 14, 2026 | 4 |
| Fonteyne Paul R. | Director | 0 | May 14, 2026 | 2 |
| Nicholson Nur | Chief Technical Officer | 0 | May 14, 2026 | 5 |
| Chopas James George | VP/Chief Accounting Officer | 0 | May 14, 2026 | 5 |
| DeLong Mark Jeffrey | Chief Business & Strat Officer | 0 | May 14, 2026 | 6 |
| Baumal Caroline | Chief Medical Officer | 0 | May 14, 2026 | 5 |
| Walbert Keli | Director | 0 | May 14, 2026 | 2 |
| Boucher Kelley | Chief People Officer | 0 | May 14, 2026 | 2 |
| Meltzer Leslie | Chief Research and Development | 0 | May 14, 2026 | 2 |
| Townsend Adam J. | Chief Commercial Officer | 84,050 | Jan 30, 2025 | 0 |
| Lewis Karen | Chief People Officer | 70,251 | Jan 30, 2025 | 0 |
| Eisele Jeffrey | Chief Development Officer | 55,312 | Jan 30, 2025 | 0 |
| Scheibler Lukas | Chief Research Officer | 68,299 | Dec 5, 2023 | 0 |
| Brown Victoria L. | Program Team Lead | 23,556 | Jan 24, 2023 | 0 |
| Grossi Federico | Chief Medical Officer | 94,884 | Jan 9, 2023 | 0 |
| Morningside Venture Investments Ltd | 10% Owner | 12,806,342 | Nov 18, 2021 | 0 |
| Perry Nicole D | Vice President - Accounting | 4,847 | Aug 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Perry Nicole DVice President - Accounting | SSale | −1.00K | $64.00 | −$64.0K | −17.1%4.85K after | |
| Jul 9, 2021 (view filing) | Jul 8 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −250 | $65.68 | −$16.4K | −0.4%63.7K after | |
| Jul 15, 2021 (view filing) | Jul 14 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −500 | $64.68 | −$32.3K | −0.8%63.2K after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Machiels AlecDirector | SSale | −2.50K | $62.30 | −$155.8K | −0.4%669.5K after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | DeLong Mark JeffreySenior Vice President | SSale | −1.00K | $62.30 | −$62.3K | −9.5%9.49K after | |
| Jul 22, 2021 (view filing) | Jul 21 | 1 day | DeLong Mark JeffreySenior Vice President | SSale | −1.00K | $65.00 | −$65.0K | −9.5%9.49K after | |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | Perry Nicole DVice President - Accounting | SSale | −1.00K | $63.99 | −$64.0K | −17.1%4.85K after | |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −250 | $63.99 | −$16.0K | −0.4%62.9K after | |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Machiels AlecDirector | SSale | −2.50K | $56.95 | −$142.4K | −0.4%669.5K after | |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −750 | $33.26 | −$24.9K | −1.1%66.2K after | |
| Oct 15, 2021 (view filing) | Oct 14 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −750 | $34.57 | −$25.9K | −1.1%65.4K after | |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −625 | $30.70 | −$19.2K | −1.0%64.8K after | |
| Nov 17, 2021 (view filing) | Nov 4-15 | 13 daysLate | Machiels AlecDirector | SSale | −6.00K | $39.25 | −$235.5K | −0.9%669.5K after | 2 lots |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −625 | $43.50 | −$27.2K | −1.0%64.5K after | |
| Nov 18, 2021 (view filing) | Nov 18 | Same day | Morningside Venture Investments Ltd10% Owner | PPurchase | +250.0K | $40.00 | +$10.0M | +2.0%12.8M after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $42.40 | −$15.9K | −0.6%64.1K after | |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Machiels AlecDirector | SSale | −3.00K | $42.88 | −$128.6K | −0.4%669.5K after | |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $42.88 | −$16.1K | −0.5%70.7K after | |
| Dec 23, 2021 (view filing) | Dec 22 | 1 day | Watson David O.General Counsel | SSale | −10.6K | $47.81 | −$505.4K | −8.9%108.7K after | 3 lots |
| Dec 28, 2021 (view filing) | Dec 27 | 1 day | Watson David O.General Counsel | SSale | −1.20K | $48.50 | −$58.2K | −1.1%107.5K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $47.31 | −$17.7K | −0.5%70.4K after | |
| Jan 19, 2022 (view filing) | Jan 14 | 5 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $40.56 | −$15.2K | −0.5%78.5K after | |
| Jan 19, 2022 (view filing) | Jan 14 | 5 days | Machiels AlecDirector | SSale | −1.25K | $40.56 | −$50.7K | −0.2%673.8K after | |
| Feb 1, 2022 (view filing) | Jan 31 | 1 day | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −1.23K | $38.47 | −$47.4K | −2.2%53.9K after | |
| Feb 2, 2022 (view filing) | Feb 1 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $40.58 | −$15.2K | −0.4%103.6K after | |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −10.0K | $45.00 | −$450.0K | −15.7%53.9K after | |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −10.0K | $50.00 | −$500.0K | −15.8%53.2K after | |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −1.67K | $46.80 | −$78.0K | −3.1%51.5K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Machiels AlecDirector | SSale | −1.25K | $45.43 | −$56.8K | −0.2%673.8K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $45.43 | −$17.0K | −0.4%106.1K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $43.53 | −$16.3K | −0.3%109.8K after | |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Machiels AlecDirector | SSale | −1.25K | $39.57 | −$49.5K | −0.5%259.5K after | |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −375 | $39.57 | −$14.8K | −0.3%116.4K after | |
| Apr 4, 2022 (view filing) | Apr 1 | 3 days | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −11.5K | $55.05 | −$632.9K | −18.0%52.2K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −3.50K | $56.96 | −$199.6K | −6.3%52.2K after | 3 lots |
| Apr 6, 2022 (view filing) | Apr 5 | 1 day | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −609 | $60.09 | −$36.6K | −1.2%52.2K after | |
| Apr 18, 2022 (view filing) | Apr 14 | 4 days | Machiels AlecDirector | SSale | −1.25K | $50.90 | −$63.6K | −0.5%263.8K after | |
| Apr 22, 2022 (view filing) | Apr 20 | 2 days | DeLong Mark JeffreySenior Vice President | SSale | −7.00K | $52.53 | −$367.7K | −19.7%28.5K after | |
| Apr 27, 2022 (view filing) | Apr 25 | 2 days | Watson David O.General Counsel | SSale | −5.00K | $50.00 | −$250.0K | −3.8%125.6K after | |
| May 2, 2022 (view filing) | Apr 29 | 3 days | Deschatelets PascalChief Scientific Officer | SSale | −4.00K | $44.43 | −$177.7K | −0.4%891.8K after | |
| May 3, 2022 (view filing) | May 2 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −2.50K | $43.56 | −$108.9K | −2.2%112.1K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Machiels AlecDirector | SSale | −1.25K | $39.18 | −$49.0K | −0.5%263.8K after | |
| May 31, 2022 (view filing) | May 27 | 4 days | Scheibler LukasCHIEF INNOVATION OFFICER | SSale | −10.0K | $43.00 | −$430.0K | −19.9%40.4K after | |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | Grossi FedericoCHIEF MEDICAL OFFICER | SSale | −2.50K | $41.78 | −$104.5K | −2.2%109.6K after | |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Deschatelets PascalChief Scientific Officer | SSale | −12.0K | $44.09 | −$529.1K | −1.3%891.8K after | |
| Jun 17, 2022 (view filing) | Jun 15 | 2 days | Machiels AlecDirector | SSale | −1.25K | $39.29 | −$49.1K | −0.5%263.8K after | |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | DeLong Mark JeffreySenior Vice President | SSale | −10.0K | $41.79 | −$417.9K | −25.5%29.3K after | |
| Jun 22, 2022 (view filing) | Jun 17 | 5 days | Brown Victoria L.Program Team Lead | SSale | −2.70K | $45.00 | −$121.4K | −9.7%25.0K after | |
| Jun 23, 2022 (view filing) | Jun 22 | 1 day | Watson David O.General Counsel | SSale | −10.0K | $44.51 | −$445.1K | −8.0%115.6K after | |
| Jun 24, 2022 (view filing) | Jun 23 | 1 day | Dunlop A. SinclairDirector | SSale | −15.0K | $45.00 | −$675.0K | −5.0%285.7K after |